Overactive Bladder Syndrome

Overactive Bladder Syndrome Clinical Trial

Official title:

The Role of Primary Nocturnal Enuresis in the Etiology of Overactive Bladder Syndrome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05151081
• Other study ID #: 2020/04
• Status: Completed
• Start date: February 3, 2020
• Est. completion date: October 15, 2021

Study information

• Verified date: November 2021
• Source: Hisar Intercontinental Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Purpose:

A lot of etiological factors related to overactive bladder (OAB) has been investigated. However, the role of primary nocturnal enuresis (NE), which is characterized with childhood night time incontinence, in the etiology of OAB is controversial. This study aims to evaluate the effect of NE in patients diagnosed with OAB.

Metod Between january-september 2021, the data of patients who applied to the urology outpatientclinic with OAB symptoms were collected. Patients with a history of chronic systemic disease, previous medical treatment for OAB and who did not accept to join the study were excluded. According to the diagnosis of childhood NE, patients were divided into two groups. Demographic data hav been recorded. Frequency of incontinence, number of day time void and nocturia were evaluated according to a 3 day voiding diary. Inaddition, max. Urinary flowr atio (Qmax), bladder Wall thickness and postvoid residual volüme rates were determined using uroflowmetry and pelvic ultrasound.

Description:

A prospective randomized study is a study based on basic urological data. This study aims to evaluate the effect of NE in patients diagnosed with OAB.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 87
• Est. completion date: October 15, 2021
• Est. primary completion date: July 3, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• overactive bladder syndrome

• enuresis nocturna

Exclusion Criteria:

• diabetes mellitus,

• neurological diseases

• bladder outlet obstruction,

• active urinary system infection

Related Conditions & MeSH terms

• Enuresis
• Enuresis, Nocturnal
• Nocturnal Enuresis
• Overactive Bladder Syndrome
• Syndrome
• Urinary Bladder, Overactive
• Urinary Incontinence

Intervention

Other:
• basicly
Do not repeat information already included in arm/group descriptions.

Locations

Country	Name	City	State
Turkey	Hisar Intercontinental Hospital	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Hisar Intercontinental Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	A diagnose of childhood NE in OAB patients can cause more severe semptomatologic progression	This study aims to evaluate the effect of NE in patients diagnosed with OAB.Definition of NE is urinary incontinence in children over the age of 5 during sleep ,as defined by International Children's Continence Society.; Overactive Bladder Symptom Score (OABSS) questionnaire were used for the assessment of OAB. OABSS is an questionnaire ,consisting of 4 questions, was prepared by Homma et al. in 2006	1 years